Regeneron Pharmaceuticals (REGN)

Cash & Equivalents

$2.46B

Quarterly · Period ending: · USD

REGN logo

REGN Cash & Equivalents

Latest reported$2.46B
REGN Quarterly Cash & Equivalents ($21.80M → $2.46B)
High-resolution chart · PNG

REGN cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
2,455,800,000
2,962,600,000
3,118,100,000
2,506,400,000
1,995,800,000
3,090,200,000
2,488,200,000
2,011,800,000
1,920,700,000
2,602,000,000
2,730,000,000
2,152,300,000
1,937,200,000
3,916,300,000
3,105,900,000
3,491,300,000
3,395,100,000
3,345,700,000
2,885,600,000
3,432,400,000
2,072,200,000
1,437,900,000
2,193,700,000
1,573,000,000
1,992,200,000
2,208,200,000
1,617,800,000
1,384,800,000
1,045,500,000
1,708,500,000
1,467,700,000
1,087,843,000
917,876,000
1,019,491,000
812,733,000
792,065,000
744,313,000
811,773,000
535,203,000
920,359,000
646,508,000
604,214,000
809,102,000
654,587,000
390,554,000
507,907,000
648,719,000
646,554,000
600,135,000
461,858,000
535,608,000
263,211,000
381,675,000
180,362,000
230,276,000
118,998,000
171,943,000
394,585,000
483,610,000
206,395,000
254,312,000
135,376,000
112,572,000
325,286,000
112,000,000
117,311,000
207,075,000
250,321,000
271,466,000
199,097,000
247,796,000
314,684,000
292,129,000
520,875,000
498,925,000
97,416,000
109,643,000
156,484,000
237,876,000
167,662,000
114,960,000
182,332,000
184,508,000
176,093,000
145,201,000
147,816,000
101,234,000
105,047,000
122,833,000
174,034,000
118,285,000
298,617,000
129,659,000
191,586,000
80,077,000
75,574,000
69,374,000
135,469,000
247,393,000
99,974,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.